Evidence map›Paper›PMID 30011030›Full record

ArticleNucleic acids research2018

Integrating Rio1 activities discloses its nutrient-activated network in Saccharomyces cerevisiae.

Maria G Iacovella, Michael Bremang, Omer Basha, Luciano Giacò, Walter Carotenuto, Cristina Golfieri, Barnabas Szakal, Marianna Dal Maschio, Valentina Infantino, Galina V Beznoussenko and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 4 countries.

Maria G IacovellaDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
Michael BremangDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
Omer BashaDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, POB 653, Beer-Sheva 84105, Israel.
Luciano GiacòDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
Walter CarotenutoThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139 Milan, Italy.
Cristina GolfieriDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
Barnabas SzakalThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139 Milan, Italy.
Marianna Dal MaschioDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
Valentina InfantinoDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
Galina V BeznoussenkoThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139 Milan, Italy.
Chinnu R JosephThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139 Milan, Italy.
Clara VisintinDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
Alexander A MironovThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139 Milan, Italy.
Rosella VisintinDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
Dana BranzeiThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139 Milan, Italy.
Sébastien Ferreira-CercaLehrstuhl für Biochemie III, Universität Regensburg, Universitätsstraße 31, 93053 Regensburg, Germany.
Esti Yeger-LotemDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, POB 653, Beer-Sheva 84105, Israel.
Peter De WulfDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.
European Institute of Oncology · ITIFOM · ITBen-Gurion University of the Negev · ILProteome Sciences (United Kingdom) · GBUniversity of Regensburg · DEUniversity of Trento · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Saccharomyces cerevisiae kinase/adenosine triphosphatase Rio1 regulates rDNA transcription and segregation, pre-rRNA processing and small ribosomal subunit maturation. Other roles are unknown. When overexpressed, human ortholog RIOK1 drives tumor growth and metastasis. Likewise, RIOK1 promotes 40S ribosomal subunit biogenesis and has not been characterized globally. We show that Rio1 manages directly and via a series of regulators, an essential signaling network at the protein, chromatin and RNA levels. Rio1 orchestrates growth and division depending on resource availability, in parallel to the nutrient-activated Tor1 kinase. To define the Rio1 network, we identified its physical interactors, profiled its target genes/transcripts, mapped its chromatin-binding sites and integrated our data with yeast's protein-protein and protein-DNA interaction catalogs using network computation. We experimentally confirmed network components and localized Rio1 also to mitochondria and vacuoles. Via its network, Rio1 commands protein synthesis (ribosomal gene expression, assembly and activity) and turnover (26S proteasome expression), and impinges on metabolic, energy-production and cell-cycle programs. We find that Rio1 activity is conserved to humans and propose that pathological RIOK1 may fuel promiscuous transcription, ribosome production, chromosomal instability, unrestrained metabolism and proliferation; established contributors to cancer. Our study will advance the understanding of numerous processes, here revealed to depend on Rio1 activity.

Indexed as

Cell CycleChromatinChromosome SegregationEnergy MetabolismMitochondriaPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesRibosome Subunits, Small, EukaryoticRNA, FungalSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscription, GeneticChromatinPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesRio1 protein, S cerevisiaeRNA, FungalSaccharomyces cerevisiae ProteinsTOR1 protein, S cerevisiae

Identifiers

PMID30011030
PMCPMC6125641
OpenAlexW2883638680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.